Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "MS Bio"
Home
MS Bio Pursues IPO to Fuel Expansion into Amniotic Lenses, Aesthetics, and Global Markets
MS Bio, a specialized manufacturer of human tissue graft materials and medical devices, is leveraging its upcoming initial public offering to expand...
10/06/2026, 03:25 ET
Samsung Bioepis Seeks South Korean Approval for Keytruda Biosimilar SB27
Samsung Bioepis announced on Aug. 10 that it has submitted a marketing authorization application to South Korea's Ministry of Food and Drug Safety...
08/13/2026, 11:04 ET
MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery
MSD, which has long dominated the global cancer market with its blockbuster immuno-oncology therapy Keytruda, is...
06/19/2026, 04:26 ET
SK Bioscience Accelerates Development of Next-Generation Zaire Ebola Vaccine
SK Bioscience is accelerating the development of the next-generation Ebola vaccine with funding support from the...
01/23/2026, 03:23 ET
Dr. Han Jin-hwan, Formerly of Merck (MSD), Appointed Head of New Drug Research Institute at Ligand Pharmaceuticals
Ligand Pharmaceuticals announced on the 5th that it has recruited Dr. Han Jin-hwan, formerly of Merck, as the head of...
01/04/2026, 14:33 ET
Celltrion Files for South Korean Approval of Keytruda Biosimilar CT-P51
Celltrion announced on August 24 that it has submitted a marketing authorization application to South Korea’s Ministry...
08/28/2026, 23:36 ET
Muscle Load, Not Protein Intake, Drives Real Muscle Growth
A widespread misconception—frequently amplified by aggressive marketing from the protein industry—holds that consuming...
08/14/2026, 10:18 ET
GC Biopharma Develops Advanced Platform to Track mRNA Vaccine Degradation
GC Biopharma has developed a technology platform capable of precisely analyzing how mRNA vaccines degrade when exposed...
08/13/2026, 10:18 ET
GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea
GC Biopharma’s chickenpox vaccine, Barycela Inj., is set to enter a Phase 3 clinical trial in South Korea to confirm...
07/06/2026, 03:44 ET
South Korean Biotechs Race to Conquer the Untapped Global MASH Market
Fat accumulation in the liver can trigger severe inflammation even in individuals who completely abstain from alcohol.
06/05/2026, 04:23 ET
1
2
Next